Protein kinase CK2 phosphorylates and activates p21-activated kinase 1

Molecular Biology of the Cell

Volumn 24, Issue 18, 2013, Pages 2990-2999

  Shin, Yong Jae ^a   Kim, Yong Bae ^a   Kim, Jeong Ho ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN KINASE II; COMPLEMENTARY DNA; DIMER; EPIDERMAL GROWTH FACTOR; GLUTATHIONE TRANSFERASE; GUANOSINE TRIPHOSPHATASE; LENTIVIRUS VECTOR; MONOMER; P21 ACTIVATED KINASE 1; PHOSPHATE; PHOSPHORUS 32; SHORT HAIRPIN RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPHOSPHORYLATION; AUTORADIOGRAPHY; CANCER CELL; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIQUID CHROMATOGRAPHY; MALE; MALIGNANT TRANSFORMATION; MASS SPECTROMETRY; MOUSE; MUTANT; MUTATION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; TUMOR XENOGRAFT; WESTERN BLOTTING;

ANIMALS; BIOCATALYSIS; BLOTTING, WESTERN; CASEIN KINASE II; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; ENZYME ACTIVATION; EPIDERMAL GROWTH FACTOR; HUMANS; MALE; MASS SPECTROMETRY; MICE; MODELS, BIOLOGICAL; MUTATION; P21-ACTIVATED KINASES; PHOSPHORYLATION; PHOSPHOSERINE; PROSTATE; REPRODUCIBILITY OF RESULTS;

EID: 84884478326     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E13-04-0204     Document Type: Article

References (48)

1. Al-Khouri AM, Ma Y, Togo SH, Williams S, Mustelin T (2005). Cooperative phosphorylation of the tumor suppressor phosphatase and tensin homologue (PTEN) by casein kinases and glycogen synthase kinase 3?. J Biol Chem 280, 35195-35202. (Pubitemid 41532706)
2. Arias-Romero LE, Chernoff J (2008). A tale of two Paks. Biol Cell 100, 97-108. (Pubitemid 351266767)
3. Bokoch GM (2003). Biology of the p21-activated kinases. Annu Rev Biochem 72, 743-781. (Pubitemid 36930459)
4. Bokoch GM, Wang Y, Bohl BP, Sells MA, Quilliam LA, Knaus UG (1996). Interaction of the Nck adapter protein with p21-activated kinase (PAK1). J Biol Chem 271, 25746-25749. (Pubitemid 26347400)
5. Canton DA, Olsten ME, Niederstrasser H, Cooper JA, Litchfield DW (2006). The role of CKIP-1 in cell morphology depends on its interaction with actin-capping protein. J Biol Chem 281, 36347-36359. (Pubitemid 46041369)
6. Catarzi S, Romagnoli C, Marcucci G, Favilli F, Iantomasi T, Vincenzini MT (2011). Redox regulation of ERK1/2 activation induced by sphingosine 1-phosphate in fibroblasts: involvement of NADPH oxidase and platelet-derived growth factor receptor. Biochim Biophys Acta 1810, 446-456.
7. Chong C, Tan L, Lim L, Manser E (2001). The mechanism of PAK activation. Autophosphorylation events in both regulatory and kinase domains control activity. J Biol Chem 276, 17347-17353.
8. Cory GO, Cramer R, Blanchoin L, Ridley AJ (2003). Phosphorylation of the WASP-VCA domain increases its affinity for the Arp2/3 complex and enhances actin polymerization by WASP. Mol Cell 11, 1229-1239. (Pubitemid 36645142)
9. Diella F, Gould CM, Chica C, Via A, Gibson TJ (2008). Phospho.ELM: a database of phosphorylation sites-update 2008. Nucleic Acids Res 36, D240-D244. (Pubitemid 351149729)
10. Edwards DC, Sanders LC, Bokoch GM, Gill GN (1999). Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signalling to actin cytoskeletal dynamics. Nat Cell Biol 1, 253-259. (Pubitemid 129495774)
11. Field J, Manser E (2012). The PAKs come of age: celebrating 18 years of discovery. Cell Logist 2, 54-58.
12. Goc A, Al-Azayzih A, Abdalla M, Al-Husein B, Kavuri S, Lee J, Moses K, Somanath PR (2013). P21 activated kinase-1 (Pak1) promotes prostate tumor growth and microinvasion via inhibition of transforming growth factor ? expression and enhanced matrix metalloproteinase 9 secretion. J Biol Chem 288, 3025-3035.
13. Hoffman GR, Nassar N, Cerione RA (2000). Structure of the Rho family GTP-binding protein Cdc42 in complex with the multifunctional regulator RhoGDI. Cell 100, 345-356. (Pubitemid 30353090)
14. Ji H et al. (2009). EGF-induced ERK activation promotes CK2-mediated disassociation of β-catenin from β-catenin and transactivation of β-catenin. Mol Cell 36, 547-559.
15. Kichina JV, Goc A, Al-Husein B, Somanath PR, Kandel ES (2010). PAK1 as a therapeutic target. Expert Opin Ther Targets 14, 703-725.
16. King CC, Gardiner EM, Zenke FT, Bohl BP, Newton AC, Hemmings BA, Bokoch GM (2000). p21-activated kinase (PAK1) is phosphorylated and activated by 3-phosphoinositide-dependent kinase-1 (PDK1). J Biol Chem 275, 41201-41209. (Pubitemid 32054952)
17. Kreis P, Rousseau V, Thevenot E, Combeau G, Barnier JV (2008). The four mammalian splice variants encoded by the p21-activated kinase 3 gene have different biological properties. J Neurochem 106, 1184-1197.
18. Kumar R, Gururaj AE, Barnes CJ (2006). p21-activated kinases in cancer. Nat Rev Cancer 6, 459-471.
19. Lei M, Lu W, Meng W, Parrini MC, Eck MJ, Mayer BJ, Harrison SC (2000). Structure of PAK1 in an autoinhibited conformation reveals a multistage activation switch. Cell 102, 387-397.
20. Lei M, Robinson MA, Harrison SC (2005). The active conformation of the PAK1 kinase domain. Structure 13, 769-778. (Pubitemid 40704665)
21. Li F, Adam L, Vadlamudi RK, Zhou H, Sen S, Chernoff J, Mandal M, Kumar R (2002). p21-activated kinase 1 interacts with and phosphorylates histone H3 in breast cancer cells. EMBO Rep 3, 767-773. (Pubitemid 34966016)
22. Lu W, Katz S, Gupta R, Mayer BJ (1997). Activation of Pak by membrane localization mediated by an SH3 domain from the adaptor protein Nck. Curr Biol 7, 85-94. (Pubitemid 27155617)
23. Lu Z, Cox-Hipkin MA, Windsor WT, Boyapati A (2010). 3-Phosphoinositide- dependent protein kinase-1 regulates proliferation and survival of cancer cells with an activated mitogen-activated protein kinase pathway. Mol Cancer Res 8, 421-432.
24. Manser E, Leung T, Salihuddin H, Zhao ZS, Lim L (1994). A brain serine/threonine protein kinase activated by Cdc42 and Rac1. Nature 367, 40-46. (Pubitemid 24038530)
25. Maupas-Schwalm F, Auge N, Robinet C, Cambus JP, Parsons SJ, Salvayre R, Negre-Salvayre A (2004). The sphingomyelin/ceramide pathway is involved in ERK1/2 phosphorylation, cell proliferation, and uPAR overexpression induced by tissue-type plasminogen activator. FASEB J 18, 1398-1400. (Pubitemid 39561593)
26. McDonald OB, Hannun YA, Reynolds CH, Sahyoun N (1991). Activation of casein kinase II by sphingosine. J Biol Chem 266, 21773-21776. (Pubitemid 121000247)
27. Meggio F, Pinna LA (2003). One-thousand-and-one substrates of protein kinase CK2+ FASEB J 17, 349-368. (Pubitemid 36292951)
28. Morreale A, Venkatesan M, Mott HR, Owen D, Nietlispach D, Lowe PN, Laue ED (2000). Structure of Cdc42 bound to the GTPase binding domain of PAK. Nat Struct Biol 7, 384-388. (Pubitemid 30250001)
29. Pandey A, Dan I, Kristiansen TZ, Watanabe NM, Voldby J, Kajikawa E, Khosravi-Far R, Blagoev B, Mann M (2002). Cloning and characterization of PAK5, a novel member of mammalian p21-activated kinase-II subfamily that is predominantly expressed in brain. Oncogene 21, 3939-3948. (Pubitemid 34620863)
30. Parrini MC, Lei M, Harrison SC, Mayer BJ (2002). Pak1 kinase homodimers are autoinhibited in trans and dissociated upon activation by Cdc42 and Rac1. Mol Cell 9, 73-83. (Pubitemid 34127772)
31. Parrini MC, Matsuda M, de Gunzburg J (2005). Spatiotemporal regulation of the Pak1 kinase. Biochem Soc Trans 33, 646-648. (Pubitemid 41160829)
32. Ritt DA, Zhou M, Conrads TP, Veenstra TD, Copeland TD, Morrison DK (2007). CK2 is a component of the KSR1 scaffold complex that contributes to Raf kinase activation. Curr Biol 17, 179-184. (Pubitemid 46107825)
33. Rudel T, Bokoch GM (1997). Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science 276, 1571-1574. (Pubitemid 27255323)
34. Ruzzene M, Pinna LA (2010). Addiction to protein kinase CK2: a common denominator of diverse cancer cells? Biochim Biophys Acta 1804, 499-504.
35. Sells MA, Knaus UG, Bagrodia S, Ambrose DM, Bokoch GM, Chernoff J (1997). Human p21-activated kinase (Pak1) regulates actin organization in mammalian cells. Curr Biol 7, 202-210. (Pubitemid 27164726)
36. Shin YJ, Kim JH (2012). The role of EZH2 in the regulation of the activity of matrix metalloproteinases in prostate cancer cells. PLoS One 7, e30393.
37. Strochlic TI, Viaud J, Rennefahrt UE, Anastassiadis T, Peterson JR (2010). Phosphoinositides are essential coactivators for p21-activated kinase 1. Mol Cell 40, 493-500.
38. Torres J, Pulido R (2001). The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation. J Biol Chem 276, 993-998. (Pubitemid 32096519)
39. Vadlamudi RK, Adam L, Wang RA, Mandal M, Nguyen D, Sahin A, Chernoff J, Hung MC, Kumar R (2000). Regulatable expression of p21-activated kinase-1 promotes anchorage-independent growth and abnormal organization of mitotic spindles in human epithelial breast cancer cells. J Biol Chem 275, 36238-36244.
40. Vadlamudi RK, Li F, Barnes CJ, Bagheri-Yarmand R, Kumar R (2004). p41-Arc subunit of human Arp2/3 complex is a p21-activated kinase-1-interacting substrate. EMBO Rep 5, 154-160. (Pubitemid 38401194)
41. Vazquez F, Ramaswamy S, Nakamura N, Sellers WR (2000). Phosphorylation of the PTEN tail regulates protein stability and function. Mol Cell Biol 20, 5010-5018. (Pubitemid 30431555)
42. Wang RA, Zhang H, Balasenthil S, Medina D, Kumar R (2006a). PAK1 hyperactivation is sufficient for mammary gland tumor formation. Oncogene 25, 2931-2936. (Pubitemid 43739243)
43. Wang W, Mouneimne G, Sidani M, Wyckoff J, Chen X, Makris A, Goswami S, Bresnick AR, Condeelis JS (2006b). The activity status of cofilin is directly related to invasion, intravasation, and metastasis of mammary tumors. J Cell Biol 173, 395-404.
44. Xavier CP et al. (2012). Phosphorylation of CRN2 by CK2 regulates F-actin and Arp2/3 interaction and inhibits cell migration. Sci Rep 2, 241.
45. Ye DZ, Field J (2012). PAK signaling in cancer. Cell Logist 2, 105-116.
46. Zenke FT, King CC, Bohl BP, Bokoch GM (1999). Identification of a central phosphorylation site in p21-activated kinase regulating autoinhibition and kinase activity. J Biol Chem 274, 32565-32573. (Pubitemid 129535281)
47. Zhao ZS, Lim JP, Ng YW, Lim L, Manser E (2005). The GIT-associated kinase PAK targets to the centrosome and regulates Aurora-A. Mol Cell 20, 237-249. (Pubitemid 41484169)
48. Zhao ZS, Manser E, Chen XQ, Chong C, Leung T, Lim L (1998). A conserved negative regulatory region in ?PAK, inhibition of PAK kinases reveals their morphological roles downstream of Cdc42 and Rac1. Mol Cell Biol 18, 2153-2163. (Pubitemid 28152664)